This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Yourgene Health Delists Following Novacyt Acquisition MT
Novacyt: Yourgene officially delisted in London CF
Novacyt: acquisition of Yourgene Health finalized CF
Novacyt Completes Acquisition of Yourgene Health MT
Novacyt completes buy of molecular diagnostics firm Yourgene Health AN
Novacyt UK Holdings Limited completed the acquisition of Yourgene Health Plc from BGF Investments LP, managed by BGF Investment Management Ltd. and others. CI
Tintra receives bid approach; NCC trading in line AN
UK Court OKs Novacyt's Acquisition of Yourgene Health MT
Yourgene Health Plc Launches MagBench Automated DNA Extraction Instrument and Kit for NIPT Workflows CI
Yourgene, Pathfinder, Spectral MD and Finncap to be deleted on AIM AN
Correction: Yourgene Health Shareholders Approve Novacyt UK's Takeover Proposal MT
Yourgene Health Shareholders Approve Novacyt UK's Takeover Proposal MT
Novacyt takeover of Yourgene Health closer to completion AN
Ithaca encouraged by K2; Safestyle profit warning AN
Yourgene Health inks five-year, Illumina contract extension AN
Yourgene Health plc Signs Five-Year Contract Extension with Illumina Inc CI
FTSE 100 Closes Down 0.5% On Back of Astrazeneca's Disappointing Lung-Cancer Data DJ
Miners and oil majors lead FTSE 100 march AN
Gilt Yields Rise as BOE Rate Expectations Increase DJ
Novacyt: shares in demand after Yourgene takeover CF
AIM WINNERS & LOSERS: Yourgene surges on takeover by Novacyt AN
Yourgene Health agrees to GBP17 million acquisition offer from Novacyt AN
Stocks start second half in green amid PMIs AN
Yourgene Health Surges on GBP17 Million Purchase Deal From Novacyt MT
London Stocks Seen Opening Marginally Higher as 2nd Half Trading Gets Underway DJ
Chart Yourgene Health
More charts
Yourgene Health PLC is an integrated molecular diagnostics company. The Company primarily develops, manufactures, and commercializes molecular diagnostic solutions for reproductive health, precision medicine and infectious diseases. Its segments include Genomic Technologies, which provides in vitro diagnostic products, software and instrumentation, and Genomic Services, which provides services to clinicians, third party clinical service providers and contract research organizations. Its flagship products include non-invasive prenatal tests (NIPT) for Down's Syndrome and other genetic disorders, Cystic Fibrosis screening tests, invasive rapid aneuploidy tests, and an extension into the precision medicine space with DPYD genotyping. It has a range of deoxyribonucleic (DNA) sample preparation platforms, powered by Ranger Technology, the Yourgene LightBench and Yourgene QS250, ideal for cell-free DNA applications in non-invasive prenatal tests and oncology, including liquid biopsy.
Sector
-
More about the company
  1. Stock Market
  2. Equities
  3. NIPT Stock
  4. News Yourgene Health
  5. Yourgene Health Conditionally Sells Taiwanese Subsidiary for $4 Million
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW